180 related articles for article (PubMed ID: 8878596)
1. In vitro activity of the trinem sanfetrinem (GV104326) against gram-positive organisms.
Singh KV; Coque TM; Murray BE
Antimicrob Agents Chemother; 1996 Sep; 40(9):2142-6. PubMed ID: 8878596
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria.
Chamberland S; Blais J; Hoang M; Dinh C; Cotter D; Bond E; Gannon C; Park C; Malouin F; Dudley MN
Antimicrob Agents Chemother; 2001 May; 45(5):1422-30. PubMed ID: 11302805
[TBL] [Abstract][Full Text] [Related]
3. Activity of a new glycopeptide antibiotic (LY333328) against enterococci and other resistant gram-positive organisms.
Fraise AP; Andrews J; Wise R
J Antimicrob Chemother; 1997 Sep; 40(3):423-5. PubMed ID: 9338497
[TBL] [Abstract][Full Text] [Related]
4. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal Activity and Synergy Studies of Peptide AP-CECT7121 Against Multi-resistant Bacteria Isolated from Human and Animal Soft Tissue Infections.
Delpech G; Bistoletti M; Ceci M; Lissarrague S; Bruni SS; Sparo M
Probiotics Antimicrob Proteins; 2017 Sep; 9(3):355-362. PubMed ID: 28573492
[TBL] [Abstract][Full Text] [Related]
6. Bactericidal activity and killing rate of serum against gram-positive cocci in volunteers receiving imipenem, oxacillin, vancomycin or ampicillin plus gentamicin.
Van der Auwera P; Van Laethem Y; Klastersky J
J Antimicrob Chemother; 1987 Aug; 20(2):239-49. PubMed ID: 3478329
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activity of levofloxacin and ofloxacin against gram-positive bacteria.
Eliopoulos GM; Wennersten CB; Moellering RC
Diagn Microbiol Infect Dis; 1996 May; 25(1):35-41. PubMed ID: 8831043
[TBL] [Abstract][Full Text] [Related]
8. Ceftaroline Plus Ampicillin Against Gram-Positive Organisms: Results from E-Test Synergy Assays.
D'Arezzo S; Mazzarelli A; Venditti C; Nisii C; Petrosillo N; De Giuli C; Vulcano A; Paglia MG; Bordi E; Di Caro A; Taglietti F
Microb Drug Resist; 2017 Jun; 23(4):507-515. PubMed ID: 27526275
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory and bactericidal effects of telithromycin (HMR 3647, RU 56647) and five comparative antibiotics, used singly and in combination, against vancomycin-resistant and vancomycin-susceptible enterococci.
Baltch AL; Smith RP; Ritz WJ; Bopp LH
Chemotherapy; 2001; 47(4):250-60. PubMed ID: 11399861
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria.
Malathum K; Coque TM; Singh KV; Murray BE
Antimicrob Agents Chemother; 1999 Apr; 43(4):930-6. PubMed ID: 10103202
[TBL] [Abstract][Full Text] [Related]
11. Activities and time-kill studies of selected penicillins, beta-lactamase inhibitor combinations, and glycopeptides against Enterococcus faecalis.
Hoellman DB; Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 Apr; 42(4):857-61. PubMed ID: 9559796
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci.
Messick CR; Woodward J; Pendland SL
Diagn Microbiol Infect Dis; 1998 Oct; 32(2):95-9. PubMed ID: 9823531
[TBL] [Abstract][Full Text] [Related]
13. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of gentamicin plus ampicillin on enterococci with differing sensitivity to gentamicin: a phenotypic assessment of NCCLS guidelines.
Dressel DC; Tornatore-Reuscher MA; Boschman CR; Stosor V; Zembower T; Postelnick MJ; Noskin GA; Peterson LR
Diagn Microbiol Infect Dis; 1999 Nov; 35(3):219-25. PubMed ID: 10626133
[TBL] [Abstract][Full Text] [Related]
15. Influence of high-level gentamicin resistance and beta-hemolysis on susceptibility of enterococci to the bactericidal activities of ampicillin and vancomycin.
Cercenado E; Eliopoulos GM; Wennersten CB; Moellering RC
Antimicrob Agents Chemother; 1992 Nov; 36(11):2526-8. PubMed ID: 1489198
[TBL] [Abstract][Full Text] [Related]
16. Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates.
Arias CA; Singh KV; Panesso D; Murray BE
Antimicrob Agents Chemother; 2007 Jun; 51(6):2043-7. PubMed ID: 17438057
[TBL] [Abstract][Full Text] [Related]
17. Comparative in-vitro activity of LY146032 a new peptolide, with vancomycin and eight other agents against gram-positive organisms.
Benson CA; Beaudette F; Trenholm G
J Antimicrob Chemother; 1987 Aug; 20(2):191-6. PubMed ID: 2822645
[TBL] [Abstract][Full Text] [Related]
18. Emergence of High-level Gentamicin Resistance among
Labibzadeh M; Kaydani GA; Savari M; Ekrami A
Pol J Microbiol; 2018; 67(4):401-406. PubMed ID: 30550226
[TBL] [Abstract][Full Text] [Related]
19. Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.
Rand KH; Houck HJ
Antimicrob Agents Chemother; 2004 Aug; 48(8):2871-5. PubMed ID: 15273094
[TBL] [Abstract][Full Text] [Related]
20. Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci.
Tripodi MF; Utili R; Rambaldi A; Locatelli A; Rosario P; Florio A; Ruggiero G
J Antimicrob Chemother; 1996 Apr; 37(4):727-36. PubMed ID: 8722538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
